本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

窥得儿医药

31.57
+0.75002.43%
盘后31.570.00000.00%19:36 EDT
成交量:119.39万
成交额:3,722.20万
市值:21.35亿
市盈率:-5.92
高:31.80
开:30.77
低:30.13
收:30.82
数据加载中...
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report
2024/07/30

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/24

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/29

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report